HSP90B2P and lymphoma: Furthermore, HSP70 has been considered as a potential therapeutic target and chemosensitiser in GC [51], and it has been developed into HSP vaccines for treating tumours such as melanoma, lymphoma, leukaemia, and glioblastoma [52].